Skip to main content
logo
Coeptis Therapeutics Holdings, Inc. (COEP)
NASDAQ: COEP · Real-Time Price · USD
16.40
+0.19 (1.17%)
At close: Apr 24, 2026, 4:00 PM EDT
16.70
+0.30 (1.83%)
After-hours: Apr 24, 2026, 6:06 PM EDT

COEP Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.36---0.08
Cost of Revenue
0.18----
Gross Profit
1.18---0.08
Selling, General & Admin
11.956.7213.8234.1814.12
Depreciation & Amortization Expenses
111--
Research & Development
1.282.336.670.02-
Other Operating Expenses
14.2310.0521.4934.214.12
Total Operating Expenses
28.4520.1142.9868.3928.24
Operating Income
-13.04-10.05-21.49-34.2-14.05
Interest Income
0.120.23---
Interest Expense
-0.64-0.46-0.11-0.22-0.19
Other Non-Operating Income (Expense)
1.29-0.60.33-3.160.79
Total Non-Operating Income (Expense)
0.77-0.820.22-3.380.6
Pretax Income
-12.28-10.88-21.27-37.57-13.45
Net Income
-11.92-10.68-21.27-37.57-13.45
Minority Interest in Earnings
-0.36-0.2---
Net Income to Common
-11.92-10.68-21.27-37.57-13.45
Shares Outstanding (Basic)
42111
Shares Outstanding (Diluted)
42111
Shares Change (YoY)
120.03%49.84%-135.37%-
EPS (Basic)
-2.81-5.56-16.56-2.63-24.60
EPS (Diluted)
-2.81-5.56-16.56-2.63-24.60
Shares Outstanding
5.752.121.770.980.47
Free Cash Flow
-8.6-6.65-7.24-3.88-4.49
Free Cash Flow Per Share
-2.03-3.45-5.64-3.02-8.23
Gross Margin
86.75%---100.00%
Operating Margin
-956.94%----18727.90%
Profit Margin
-900.72%----17932.40%
FCF Margin
-631.16%----5985.92%
EBITDA
-11.82-9.02-20.46-33.19-13.6
EBITDA Margin
-867.24%----18131.40%
EBIT
-13.04-10.05-21.49-34.2-14.05
EBIT Margin
-956.94%----18727.90%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q